Tumor-induced osteomalacia is a rare disease in which small tumors produce fibroblast growth factor 23 (FGF23), leading to phosphate wasting and impaired vitamin D News News CME CME ...

To the Editor: Seufert et al. (Dec. 27 issue)1 describe a man with tumor-induced (oncogenic) osteomalacia, in which the subcutaneous administration of octreotide abolished renal tubular phosphate w ...

Tumor-induced osteomalacia is a rare disease in which small tumors produce fibroblast growth factor 23 (FGF23), leading to phosphate wasting and impaired vitamin D synthesis.

Tumor-induced osteomalacia (TIO) is a rare disease characterized by slow-growing tumors that release excess levels of FGF23, which suppresses renal tubular phosphate reabsorption and the renal ...

Diagnosis: Tumor-induced osteomalacia. Management: The patient received phosphate and vitamin D supplementation in the form of potassium-phosphorus (500 mg, three times daily) and calcitriol (0.5 ...

Symptoms are due to renal phosphate wasting, resulting in hypophosphatemia and osteomalacia. TIO is caused by ectopic production of the phosphate- and vit D-regulating hormone, FGF23, ... Response of ...

New York, USA, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global tumor-induced osteomalacia market size was USD 118.25 million in 2024, estimated at USD 121.12 million in 2025, and is ...

(RTTNews) - Biopharmaceutical company Ultragenyx Pharmaceutical Inc. said the U.S. Food and Drug Administration (FDA) approved its bone disease drug Crysvita (burosumab) in the form of injection ...

Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia. Journal: Journal of Clinical Endocrinology & Metabolism Published: 2023-11-26 ...

Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review. Journal: Journal of Clinical Endocrinology & Metabolism Published: 2024-06-25 ...

Tumor-induced osteomalacia is a rare condition characterized by tumor-related renal phosphate wasting and abnormal vitamin D metabolism, which results in progressively worsening weakness, bone ...